Skip to main content
Fig. 1 | Cancer Nanotechnology

Fig. 1

From: A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablation

Fig. 1

Insufficient microwave ablation of HCC. A Cell viability of Huh7 and PLC cells after three incubations at 47 °C for 10 min each time. The corresponding residual cells were named H-Huh7 and H-PLC. B Upper panel: c-met expression in H-huh7 and H-PLC cells was assessed by Western blot analysis. Lower panel: H-huh7 and H-PLC cells were treated with miR-34a. C Cell viability of H-huh7 and H-PLC cells after treatment with As2O3(As), miR34a and their combination. *p < 0.05, **p < 0.01 compared with the control

Back to article page